Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hypofractionated boost to the dominant tumor region with intensity modulated stereotactic radiotherapy for prostate cancer: a sequential dose escalation pilot study.
Miralbell R, Mollà M, Rouzaud M, Hidalgo A, Toscas JI, Lozano J, Sanz S, Ares C, Jorcano S, Linero D, Escudé L. Miralbell R, et al. Among authors: escude l. Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):50-7. doi: 10.1016/j.ijrobp.2009.07.1689. Epub 2009 Nov 10. Int J Radiat Oncol Biol Phys. 2010. PMID: 19910135
Twice-weekly hypofractionated intensity-modulated radiotherapy for localized prostate cancer with low-risk nodal involvement: toxicity and outcome from a dose escalation pilot study.
Zilli T, Jorcano S, Rouzaud M, Dipasquale G, Nouet P, Toscas JI, Casanova N, Wang H, Escudé L, Mollà M, Linero D, Weber DC, Miralbell R. Zilli T, et al. Among authors: escude l. Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):382-9. doi: 10.1016/j.ijrobp.2010.05.057. Epub 2010 Sep 29. Int J Radiat Oncol Biol Phys. 2011. PMID: 20884129
Urethra-Sparing Stereotactic Body Radiation Therapy for Prostate Cancer: Quality Assurance of a Randomized Phase 2 Trial.
Jaccard M, Zilli T, Dubouloz A, Escude L, Jorcano S, Linthout N, Bral S, Verbakel W, Bruynzeel A, Björkqvist M, Minn H, Tsvang L, Symon Z, Lencart J, Oliveira A, Ozen Z, Abacioglu U, Pérez-Moreno JM, Rubio C, Rouzaud M, Miralbell R. Jaccard M, et al. Among authors: escude l. Int J Radiat Oncol Biol Phys. 2020 Nov 15;108(4):1047-1054. doi: 10.1016/j.ijrobp.2020.06.002. Epub 2020 Jun 12. Int J Radiat Oncol Biol Phys. 2020. PMID: 32535161 Clinical Trial.
Urethra-sparing stereotactic body radiotherapy for prostate cancer: how much can the rectal wall dose be reduced with or without an endorectal balloon?
Dubouloz A, Rouzaud M, Tsvang L, Verbakel W, Björkqvist M, Linthout N, Lencart J, Pérez-Moreno JM, Ozen Z, Escude L, Zilli T, Miralbell R. Dubouloz A, et al. Among authors: escude l. Radiat Oncol. 2018 Jun 19;13(1):114. doi: 10.1186/s13014-018-1059-1. Radiat Oncol. 2018. PMID: 29921291 Free PMC article. Clinical Trial.
35 results